Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2023-06-16 | 2023-06-27 | 195201 |
TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195216 |
TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2023-06-19 | 2023-07-06 | 195487 |
TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195833 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Actual shortage | 2024-01-11 | 2024-01-18 | 215754 |
TEVA-GLYBURIDE | 2.5MG | TABLET | Actual shortage | 2024-01-18 | 2024-02-15 | 216460 |
TEVA-TADALAFIL | 2.5MG | TABLET | Actual shortage | 2024-04-25 | 2024-04-25 | 226177 |
AMPICILLIN SODIUM FOR INJECTION, USP | 2000MG | POWDER FOR SOLUTION | Resolved | 2019-06-18 | 2019-09-19 | 86942 |
FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2018-03-13 | 2018-07-30 | 42638 |
FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-01-28 | 2021-02-05 | 132630 |
FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-07-08 | 2021-10-14 | 142198 |
TEVA-EMTRICITABINE/TENOFOVIR | 200MG 300MG | TABLET | Resolved | 2020-11-06 | 2021-01-07 | 128004 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2017-03-13 | 2019-05-28 | 983 |
TEVA-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-13 | 2018-02-21 | 1769 |
TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2017-04-03 | 2017-09-06 | 5201 |
TEVA-ATAZANAVIR | 200MG | CAPSULE | Resolved | 2017-08-21 | 2017-09-19 | 19928 |
TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2017-08-21 | 2018-02-21 | 19978 |
TEVA-ACEBUTOLOL | 200MG | TABLET | Resolved | 2018-05-22 | 2019-08-20 | 50026 |
ACT CELECOXIB | 200MG | CAPSULE | Resolved | 2018-12-04 | 2019-04-11 | 68583 |
ACT CELECOXIB | 200MG | CAPSULE | Resolved | 2018-12-04 | 2019-08-06 | 68586 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |